UPC Analytics
ENDE
Overview · Filed: —

UPC_APP_34350/2025

USE OF SUBSTITUTED AMINOPROPIONATE COMPOUNDS IN TREATMENT OF SARS-COV-2 INFECTION

Procedural & sub-applicationsOther ProceduralMilan CDGeneric application—
OverviewDecisionsDocumentsTimeline
Parties

Claimants

  • Gilead Sciences, Inc.
Reps: Christine Kanz (HOYNG ROKH MONEGIER)

Respondents

  • Academy of Military Medical Sciences
Reps: (Lavoix (EPO patent representative only))
Judges
  • Judge-rapporteur
Patents
  • EP 3 854 403
CPC codes: A61P31/14, C07F9/6561, A61K31/685, A61P11/00, A61K31/675

Sector: Organic Chemistry

Outcome
Procedural only
Filed: —
First decided: Sep 4, 2025
Language: —